Consolidated Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 3,705	$ 0
Fund held in trust	0	16,103
Accounts receivable	19,299	0
Other receivable	14,889	0
Prepaid expense	18,757	0
Due from related party	8,901	15,000
Deferred share issuance cost	254,750	0
Total Current Assets	320,301	31,103
Other Assets
Property and Equipment	17,160	0
Intangible assets, net	0	40,531
Total Assets	337,461	71,634
Current Liabilities
Accounts payable and accrued liabilities	109,281	66,367
Accrued interest	0	3,253
Due to related party	11,682	2,154
Convertible note	0	153,520
Stock payable	688,934	0
Total Current Liabilities	809,897	225,294
Loan payable	0	148,442
Total Liabilities	809,897	373,736
STOCKHOLDERS' DEFICIT
Common Stock: $0.001 par value, 75,000,000 shares authorized, 61,254,427 shares and 4,046,760 shares issued and outstanding, respectively	61,254	4,047
Additional paid-in capital	46,928,116	143,843
Accumulated deficit	(37,619,073)	(458,919)
Accumulated other comprehensive income	2,379	0
Less: Deferred compensation (including $34,890 and $0 of deferred compensation to related party as December 31, 2025 and 2024, respectively)	(9,857,820)	0
Total equity (deficit) attributed to Transuite.Org. Inc.	(485,144)	(311,029)
Non-controlling interest	12,708	8,927
Total Stockholders' Deficit	(472,436)	(302,102)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 337,461	$ 71,634